Naltrexone (International)
Note: In some countries, this medicine may only be approved for veterinary use.
In the US, Naltrexone (naltrexone systemic) is a member of the following drug classes: antidotes, drugs used in alcohol dependence and is used to treat Alcohol Use Disorder, Fibromyalgia, Opioid Use Disorder, Smoking Cessation and Trichotillomania.
US matches:
- Naltrexone
- Naltrexone injection
- Naltrexone (Intramuscular)
- Naltrexone (Oral)
- Naltrexone and bupropion
- Naltrexone Tablets
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N07BB04
CAS registry number (Chemical Abstracts Service)
0016590-41-3
Chemical Formula
C20-H23-N-O4
Molecular Weight
341
Therapeutic Categories
Antidote
Opioid receptor antagonist
Chemical Name
Morphinan-6-one, 17-(cyclopropylmetyl)-4,5-epoxy-3,14-dihydroxy-, (5α)-
Foreign Names
- Naltrexonum (Latin)
- Naltrexon (German)
- Naltrexone (French)
- Naltrexona (Spanish)
Generic Names
- Naltrexone (OS: DCF, DCIT, USAN, BAN)
- UM 792 (IS)
- Naltrexone Hydrochloride (OS: BANM)
- EN-1639 A (DuPont Merck) (IS)
- Naltrexone Hydrochloride (PH: BP 2018, USP 41)
- Naltrexone hydrochloride (PH: Ph. Eur. 9)
- Naltrexoni hydrochloridum (PH: Ph. Eur. 9)
Brand Names
- Abernil
Medochemie, Cyprus - Adepend
Norameda, Lithuania; Orpha-Devel, Slovenia; Providens, Croatia (Hrvatska); UAB “STADA-Nizhpharm-Baltija”, Estonia - Mysimba [+ Bupropion]
Orexigen, Lithuania; Orexigen, Latvia; Orexigen Therapeutics Ireland, Slovenia - Mysimba 8 mg/90 mg retard [+ Bupropion]
Orexigen, Hungary - Nalerona
ABL Pharma, Peru; Laboratorios Andromaco, Chile - Naltrexone
Haupt Pharma Wolfratshausen, Serbia - Naltrexone Accord
Accord Healthcare, France; Accord, Lithuania - Naltrexone Accord Healthcare
Accord Healthcare, Italy - Naltrexone AOP
AOP Orphan, Lithuania - Naltrexone AOP 50 mg
AOP, Hungary - Naltrexone Hydrochloride
Accord Healthcare, Cyprus - Naltrexone Mylan
Mylan, Cyprus - Naprosyne EC-500
CSL Behring, Luxembourg - Uninaltrex
União Química, Brazil - Vivitrol
Alkermes, Russian Federation; Alkermes, United States - Abernil
Medochemie, Malta; Medochemie Vietnam, Vietnam - Addtrex
Rusan Pharma Ltd., Georgia - Adepend
AOP Orphan, Bulgaria; Orpha Devel, Czech Republic; Orpha-Devel, Denmark; Orpha-Devel, Poland - Adepend 50mg
AOP Orphan Pharmaceuticals, United Kingdom; Desitin, Germany; Orpha, Hungary - Anarcol
October Pharma, Egypt - Antaxone
Zambon, Georgia; Zambon, Italy - Apo-Naltrexone
Apotex, Australia; Apotex, Canada - Contrave [+ Bupropion]
Orexigen, United States - Dependex 50 mg
Amomed Pharma, Austria - Destoxican
Pentafarma, Portugal - Embeda [+ Morphine]
Alpharma, United States - Ethylex
Dem Ilac, Turkey - Ethylex 50 mg
Orpha-Devel, Austria - Mysimba [+ Bupropion]
CentralPharma, Estonia; Consilient, Ireland; Consilient Health, United Kingdom; Navamedic, Denmark; Navamedic, Finland; Navamedic, Sweden; Orexigen, Czech Republic; Orexigen, Norway; Orexigen Therapeutics, Romania; Orexigen Therapeutics Ireland Ltd, Greece; Orexigen Therapeutics Ireland, Portugal; Rovi, Spain; Valeant, Slovakia - Nalcotrex
Ariston, Argentina - Nalerona
Silesia, Paraguay - Nalorex
Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Central Procurement & Supplies Unit, Malta; L. Molteni & C. dei F.lli Alitti Società di Esercizio, Italy - Nalorex 50mg
Bristol-Myers Squibb, Luxembourg - Naltraccord
Teva, New Zealand - Naltrax
Navana, Bangladesh - Naltrexin
Yungjin, South Korea - Naltrexin 50mg
OrPha Swiss, Switzerland - Naltrexon Abcur
Molteni Farmaceutici, Sweden - Naltrexon Accord
Accord Healthcare, Denmark - Naltrexon AOP
AOP Orphan Pharmaceuticals, Denmark - Naltrexon HCl aop
Desitin, Germany; Orphan Europe, Netherlands - Naltrexon HCl Sandoz
Sandoz, Netherlands - Naltrexon Hydrochloride Accord
Accord Healthcare, Netherlands - Naltrexon Vitaflo
AOP Orphan Pharmaceuticals, Finland; AOP Orphan Pharmaceuticals, Sweden - Naltrexona Accord
Accord, Spain; Accord, Portugal - Naltrexona Destoxican
Pentafarma, Portugal - Naltrexona Torrex
Chiesi Pharmaceuticals, Romania - Naltrexone Accord
Accord Healthcare, Belgium; Accord Healthcare, Bulgaria; Accord Healthcare, Estonia; Accord Healthcare, Latvia; Accord Healthcare, Sweden - Naltrexone AOP
AOP, Latvia; Providens, Croatia (Hrvatska) - Naltrexone GH
Generic Health, Australia - Naltrexone HCL L.Molteni
L. Molteni, Hong Kong - Naltrexone Hydrochloride
Accord Healthcare, United Kingdom; Accord Healthcare, Malta; Accord Healthcare, United States; Apotex, United States; Barr, United States; Elite, United States; Mallinckrodt, United States; Sun Pharma, United States - Naltrexone Hydrochloride Accord
Accord Healthcare, Poland - Naltrexone Hydrochloride Sterinova
Sterinova, Canada - Naltrexone Mylan
Mylan, France - Naltrexone POA Pharma
POA, Norway; POA Pharma, Denmark; POA Pharma, Sweden - Naltrexon-HCI neuraxpharm
neuraxpharm Arzneimittel, Germany - Naltrexonhydrochlorid Accord
Accord Healthcare, Germany - Naltrexonhydrochloride PCH
Pharmachemie, Netherlands - Narcoral
Sirton, China; Sirton Medicare, Italy - Nemexin
Bristol-Myers Squibb, Germany - Nuo Xin Sheng
Sihuan Pharmaceutical Factory, China - Nutrexon
Nufarindo, Indonesia - Phaltrexia
Pharos, Indonesia - Prodetoxon
ZAO, Georgia - Regental
Teva, Uruguay - Revez
S.Chobet, Argentina - Revia
Bristol-Myers Squibb, France; Bristol-Myers Squibb, New Zealand; Cristália, Brazil; Du Pont, Kuwait; Gervasi, Spain; Jeil, South Korea; Tchero, Egypt; Torrex Chiesi, Lithuania - ReVia
Bristol-Myers Squibb, Australia; Teva Canada, Canada - Revia 50 mg
Chiesi Pharmaceuticals, Austria; Eurim-Pharm, Austria - Trexonil [veterinary use]
Wildlife Laboratories, United States; Wildlife Pharma, South Africa
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
